VÁRIOS MEDICAMENTOS

ID 10588227 · Portal BASE
Price
Base Price
€25,885 .00
Effective Price
€25,885 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)
CPV Code
33000000
Location
Portugal, Setúbal, Setúbal
Bidder Count
—
Winners
BAXTER - MÉDICO FARMACÊUTICA, LDA
NIF 503347345
Company
TEVA PHARMA - PRODUTOS FARMACÊUTICOS LDA
NIF 507045491
Company
MERCK SHARP & DOHME LDA
NIF 500191360
Company
FRESENIUS KABI PHARMA PORTUGAL LDA
NIF 504293753
Company
ACCORD HEALTHCARE, UNIPESSOAL LDA
NIF 508622263
Company
LABESFAL - LABORATÓRIOS ALMIRO S.A.
NIF 501169580
Company
ABBVIE, LDA
NIF 510229050
Company
SPACEINSP DISPOSITIVOS MEDICOS, LDA
NIF 514126329
Company
PAUL HARTMANN LDA
NIF 502271728
Company
GENERIS - FARMACÊUTICA, S.A.
NIF 508107997
Company
Accord Healthcare, Unipessoal (508622263), Takeda Farmacêuticos Portugal, Lda (502801204), GlaxoSmithKline - Produtos Farmacêuticos, Lda (500139962), Hikma Farmaceutica (Portugal) Lda (502266791), LAB. PFIZER, LDA. (500162166), Zentiva Portugal, Lda.
NIF 503103551
Company
IPSEN PORTUGAL - PRODUTOS FARMACEUTICOS S.A.
NIF 502609800
Company
HIKMA FARMACÊUTICA (PORTUGAL) SA. (502266791), Glaxo SmithKline Farma (500139962), JOHNSON & JOHNSON, LDA (500153370), JABA RECORDATI, SA. (500492867), MERCK SHARP & DOHME,LDA (500191360), BOEHRINGER INGELHEIM, LDA.
NIF 500537410
Company
OVERPHARMA - PRODUTOS MÉDICOS E FARMACÊUTICOS LDA
NIF 505792362
Company
BRISTOL - MYERS SQUIBB FARMACÊUTICA PORTUGUESA, S.A.
NIF 500048193
Company
Logista, Lda.
NIF 503538108
Company
CELGENE, SOCIEDADE UNIPESSOAL LDA
NIF 507791690
Company
LILLY-PORTUGAL PRODUTOS FARMACÊUTICOS LDA
NIF 500165602
Company
KVTECH PORTUGAL -PRODUTOS MEDICOS, UNIPESSOAL,LDA.
NIF 508671531
Company
Dates
Publication
28 Feb 2024
Celebration
09 Feb 2024
Contracting Entity
Centro Hospitalar de Setúbal, EPE
NIF 507606787
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 40 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
28 Feb 2024
Signing Date
09 Feb 2024
Days Late
19
Rule
A2/A3 late publication: 19 days after signing (threshold: 10)
Detected 2026-03-06